Supplementary Figure S1 from Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia
Authors:
- Hiroki TanakaHTHiroki Tanaka
- Hiroshi FujiwaraHFHiroshi Fujiwara
- Fumihiro OchiFOFumihiro Ochi
- Kazushi TanimotoKTKazushi Tanimoto
- Nicholas CaseyNCNicholas Casey
- Sachiko OkamotoSOSachiko Okamoto
- Junichi MinenoJMJunichi Mineno
- Kiyotaka KuzushimaKKKiyotaka Kuzushima
- Hiroshi ShikuHSHiroshi Shiku
- Takashi SugiyamaTSTakashi Sugiyama
- A. John BarrettABA. John Barrett
- Masaki YasukawaMYMasaki Yasukawa
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)